TCS’ ADD Suite wins India Pharma Award 2019

07 Dec 2019 Evaluate

Tata Consultancy Services’ (TCS) cloud-based clinical solutions and services suite -- TCS Advanced Drug Development (ADD), has won an award in the category Excellence in Ancillary Pharma Services, at the India Pharma Awards 2019.

The India Pharma Awards bring together industry pioneers and recognize outstanding examples of innovation that improve the pharma industry. The company was recognized for its leadership in leveraging automation, artificial intelligence (AI) and IoT through its intellectual property and commercial-off-the-shelf offerings, to digitize and transform patient engagement, metadata management and regulatory submissions for life sciences organizations.

Tata Consultancy Services is an IT services, consulting and business solutions provider that has been partnering with the world’s largest businesses in their transformation journeys for the last fifty years.

TCS Share Price

3853.55 -20.65 (-0.53%)
24-Apr-2024 13:11 View Price Chart
Peers
Company Name CMP
TCS 3853.55
Infosys 1433.50
HCL Tech. 1481.20
Wipro 462.00
Tech Mahindra 1190.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.